MOG Antikörper (AA 60-110) (Cy3)
Kurzübersicht für MOG Antikörper (AA 60-110) (Cy3) (ABIN668484)
Target
Alle MOG Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 60-110
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human MOG
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM: (1:20-100), IF(IHC-P): (1:50-200)
Optimal working dilution should be determined by the investigator. -
Kommentare
-
Exitation/Emission: 512,550nm/570,615nm
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4 °C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- MOG (Myelin Oligodendrocyte Glycoprotein (MOG))
-
Andere Bezeichnung
- MOG
-
Hintergrund
-
Mediates homophilic cell-cell adhesion (By similarity). Minor component of the myelin sheath. May be involved in completion and/or maintenance of the myelin sheath and in cell-cell communication.
Synonyms: BTN6, BTNL11, MOGIG2, NRCLP7, Myelin-oligodendrocyte glycoprotein, MOG
Subcellular locations: Extracellular -
Gen-ID
- 4340
-
UniProt
- Q16653
Target
-